img

Global Venous Thromboembolism Treatment Options Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Venous Thromboembolism Treatment Options Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The most common treatment for deep vein thrombosis is the use of anticoagulants, also known as blood thinners. These medicines, which can be taken by injection or pill, can reduce your blood's ability to clot. They don't break down existing clots, but they prevent them from getting bigger and reduce the risk of more clots forming. Injectable drugs can be given either subcutaneously or intravenously.
Global Venous Thromboembolism Treatment Options market is projected to reach US$ 463.6 million in 2033, increasing from US$ 356.5 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2033. Demand from Hospitals and Catheterisation Laboratories are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Venous Thromboembolism Treatment Options market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AngioDynamics
Cardinal Health Inc.
BTG International Ltd.
Stryker Corporation
DJO Global Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.
Janssen Pharmaceuticals, Inc
Segment by Type
Upper Pneumatic Compression Sleeves
Lower Pneumatic Compression Sleeves
Permanent Inferior Vena Cava Filters
Others

Segment by Application


Hospitals
Catheterisation Laboratories
Ambulatory Surgical Centers

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Venous Thromboembolism Treatment Options market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Venous Thromboembolism Treatment Options, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Venous Thromboembolism Treatment Options industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Venous Thromboembolism Treatment Options in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Venous Thromboembolism Treatment Options introduction, etc. Venous Thromboembolism Treatment Options Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Venous Thromboembolism Treatment Options market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Venous Thromboembolism Treatment Options Market Overview
1.1 Venous Thromboembolism Treatment Options Product Overview
1.2 Venous Thromboembolism Treatment Options Market Segment by Type
1.2.1 Upper Pneumatic Compression Sleeves
1.2.2 Lower Pneumatic Compression Sleeves
1.2.3 Permanent Inferior Vena Cava Filters
1.2.4 Others
1.3 Global Venous Thromboembolism Treatment Options Market Size by Type
1.3.1 Global Venous Thromboembolism Treatment Options Market Size Overview by Type (2018-2033)
1.3.2 Global Venous Thromboembolism Treatment Options Historic Market Size Review by Type (2018-2023)
1.3.3 Global Venous Thromboembolism Treatment Options Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Venous Thromboembolism Treatment Options Sales Breakdown by Type (2018-2023)
1.4.2 Europe Venous Thromboembolism Treatment Options Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Venous Thromboembolism Treatment Options Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Venous Thromboembolism Treatment Options Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Venous Thromboembolism Treatment Options Sales Breakdown by Type (2018-2023)
2 Global Venous Thromboembolism Treatment Options Market Competition by Company
2.1 Global Top Players by Venous Thromboembolism Treatment Options Sales (2018-2023)
2.2 Global Top Players by Venous Thromboembolism Treatment Options Revenue (2018-2023)
2.3 Global Top Players by Venous Thromboembolism Treatment Options Price (2018-2023)
2.4 Global Top Manufacturers Venous Thromboembolism Treatment Options Manufacturing Base Distribution, Sales Area, Product Type
2.5 Venous Thromboembolism Treatment Options Market Competitive Situation and Trends
2.5.1 Venous Thromboembolism Treatment Options Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Venous Thromboembolism Treatment Options Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Venous Thromboembolism Treatment Options as of 2022)
2.7 Date of Key Manufacturers Enter into Venous Thromboembolism Treatment Options Market
2.8 Key Manufacturers Venous Thromboembolism Treatment Options Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Venous Thromboembolism Treatment Options Status and Outlook by Region
3.1 Global Venous Thromboembolism Treatment Options Market Size and CAGR by Region: 2018 VS 2022 VS 2033
3.2 Global Venous Thromboembolism Treatment Options Historic Market Size by Region
3.2.1 Global Venous Thromboembolism Treatment Options Sales in Volume by Region (2018-2023)
3.2.2 Global Venous Thromboembolism Treatment Options Sales in Value by Region (2018-2023)
3.2.3 Global Venous Thromboembolism Treatment Options Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Venous Thromboembolism Treatment Options Forecasted Market Size by Region
3.3.1 Global Venous Thromboembolism Treatment Options Sales in Volume by Region (2024-2033)
3.3.2 Global Venous Thromboembolism Treatment Options Sales in Value by Region (2024-2033)
3.3.3 Global Venous Thromboembolism Treatment Options Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global Venous Thromboembolism Treatment Options by Application
4.1 Venous Thromboembolism Treatment Options Market Segment by Application
4.1.1 Hospitals
4.1.2 Catheterisation Laboratories
4.1.3 Ambulatory Surgical Centers
4.2 Global Venous Thromboembolism Treatment Options Market Size by Application
4.2.1 Global Venous Thromboembolism Treatment Options Market Size Overview by Application (2018-2033)
4.2.2 Global Venous Thromboembolism Treatment Options Historic Market Size Review by Application (2018-2023)
4.2.3 Global Venous Thromboembolism Treatment Options Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Venous Thromboembolism Treatment Options Sales Breakdown by Application (2018-2023)
4.3.2 Europe Venous Thromboembolism Treatment Options Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Venous Thromboembolism Treatment Options Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Venous Thromboembolism Treatment Options Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Venous Thromboembolism Treatment Options Sales Breakdown by Application (2018-2023)
5 North America Venous Thromboembolism Treatment Options by Country
5.1 North America Venous Thromboembolism Treatment Options Historic Market Size by Country
5.1.1 North America Venous Thromboembolism Treatment Options Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
5.1.2 North America Venous Thromboembolism Treatment Options Sales in Volume by Country (2018-2023)
5.1.3 North America Venous Thromboembolism Treatment Options Sales in Value by Country (2018-2023)
5.2 North America Venous Thromboembolism Treatment Options Forecasted Market Size by Country
5.2.1 North America Venous Thromboembolism Treatment Options Sales in Volume by Country (2024-2033)
5.2.2 North America Venous Thromboembolism Treatment Options Sales in Value by Country (2024-2033)
6 Europe Venous Thromboembolism Treatment Options by Country
6.1 Europe Venous Thromboembolism Treatment Options Historic Market Size by Country
6.1.1 Europe Venous Thromboembolism Treatment Options Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
6.1.2 Europe Venous Thromboembolism Treatment Options Sales in Volume by Country (2018-2023)
6.1.3 Europe Venous Thromboembolism Treatment Options Sales in Value by Country (2018-2023)
6.2 Europe Venous Thromboembolism Treatment Options Forecasted Market Size by Country
6.2.1 Europe Venous Thromboembolism Treatment Options Sales in Volume by Country (2024-2033)
6.2.2 Europe Venous Thromboembolism Treatment Options Sales in Value by Country (2024-2033)
7 Asia-Pacific Venous Thromboembolism Treatment Options by Region
7.1 Asia-Pacific Venous Thromboembolism Treatment Options Historic Market Size by Region
7.1.1 Asia-Pacific Venous Thromboembolism Treatment Options Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033
7.1.2 Asia-Pacific Venous Thromboembolism Treatment Options Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Venous Thromboembolism Treatment Options Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Venous Thromboembolism Treatment Options Forecasted Market Size by Region
7.2.1 Asia-Pacific Venous Thromboembolism Treatment Options Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific Venous Thromboembolism Treatment Options Sales in Value by Region (2024-2033)
8 Latin America Venous Thromboembolism Treatment Options by Country
8.1 Latin America Venous Thromboembolism Treatment Options Historic Market Size by Country
8.1.1 Latin America Venous Thromboembolism Treatment Options Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
8.1.2 Latin America Venous Thromboembolism Treatment Options Sales in Volume by Country (2018-2023)
8.1.3 Latin America Venous Thromboembolism Treatment Options Sales in Value by Country (2018-2023)
8.2 Latin America Venous Thromboembolism Treatment Options Forecasted Market Size by Country
8.2.1 Latin America Venous Thromboembolism Treatment Options Sales in Volume by Country (2024-2033)
8.2.2 Latin America Venous Thromboembolism Treatment Options Sales in Value by Country (2024-2033)
9 Middle East and Africa Venous Thromboembolism Treatment Options by Country
9.1 Middle East and Africa Venous Thromboembolism Treatment Options Historic Market Size by Country
9.1.1 Middle East and Africa Venous Thromboembolism Treatment Options Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
9.1.2 Middle East and Africa Venous Thromboembolism Treatment Options Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Venous Thromboembolism Treatment Options Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Venous Thromboembolism Treatment Options Forecasted Market Size by Country
9.2.1 Middle East and Africa Venous Thromboembolism Treatment Options Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa Venous Thromboembolism Treatment Options Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 AngioDynamics
10.1.1 AngioDynamics Company Information
10.1.2 AngioDynamics Introduction and Business Overview
10.1.3 AngioDynamics Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AngioDynamics Venous Thromboembolism Treatment Options Products Offered
10.1.5 AngioDynamics Recent Development
10.2 Cardinal Health Inc.
10.2.1 Cardinal Health Inc. Company Information
10.2.2 Cardinal Health Inc. Introduction and Business Overview
10.2.3 Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Cardinal Health Inc. Venous Thromboembolism Treatment Options Products Offered
10.2.5 Cardinal Health Inc. Recent Development
10.3 BTG International Ltd.
10.3.1 BTG International Ltd. Company Information
10.3.2 BTG International Ltd. Introduction and Business Overview
10.3.3 BTG International Ltd. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2018-2023)
10.3.4 BTG International Ltd. Venous Thromboembolism Treatment Options Products Offered
10.3.5 BTG International Ltd. Recent Development
10.4 Stryker Corporation
10.4.1 Stryker Corporation Company Information
10.4.2 Stryker Corporation Introduction and Business Overview
10.4.3 Stryker Corporation Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Stryker Corporation Venous Thromboembolism Treatment Options Products Offered
10.4.5 Stryker Corporation Recent Development
10.5 DJO Global Inc.
10.5.1 DJO Global Inc. Company Information
10.5.2 DJO Global Inc. Introduction and Business Overview
10.5.3 DJO Global Inc. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2018-2023)
10.5.4 DJO Global Inc. Venous Thromboembolism Treatment Options Products Offered
10.5.5 DJO Global Inc. Recent Development
10.6 EKOS Corp
10.6.1 EKOS Corp Company Information
10.6.2 EKOS Corp Introduction and Business Overview
10.6.3 EKOS Corp Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2018-2023)
10.6.4 EKOS Corp Venous Thromboembolism Treatment Options Products Offered
10.6.5 EKOS Corp Recent Development
10.7 Teleflex Inc., Boston Scientific Corp.
10.7.1 Teleflex Inc., Boston Scientific Corp. Company Information
10.7.2 Teleflex Inc., Boston Scientific Corp. Introduction and Business Overview
10.7.3 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Products Offered
10.7.5 Teleflex Inc., Boston Scientific Corp. Recent Development
10.8 Janssen Pharmaceuticals, Inc
10.8.1 Janssen Pharmaceuticals, Inc Company Information
10.8.2 Janssen Pharmaceuticals, Inc Introduction and Business Overview
10.8.3 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Products Offered
10.8.5 Janssen Pharmaceuticals, Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Venous Thromboembolism Treatment Options Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Venous Thromboembolism Treatment Options Industrial Chain Analysis
11.4 Venous Thromboembolism Treatment Options Market Dynamics
11.4.1 Venous Thromboembolism Treatment Options Industry Trends
11.4.2 Venous Thromboembolism Treatment Options Market Drivers
11.4.3 Venous Thromboembolism Treatment Options Market Challenges
11.4.4 Venous Thromboembolism Treatment Options Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Venous Thromboembolism Treatment Options Distributors
12.3 Venous Thromboembolism Treatment Options Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Upper Pneumatic Compression Sleeves
Table 2. Major Company of Lower Pneumatic Compression Sleeves
Table 3. Major Company of Permanent Inferior Vena Cava Filters
Table 4. Major Company of Others
Table 5. Global Venous Thromboembolism Treatment Options Sales by Type 2018 VS 2022 VS 2033 (US$ Million)
Table 6. Global Venous Thromboembolism Treatment Options Sales by Type (2018-2023) & (K Units)
Table 7. Global Venous Thromboembolism Treatment Options Sales Market Share in Volume by Type (2018-2023)
Table 8. Global Venous Thromboembolism Treatment Options Sales by Type (2018-2023) & (US& Million)
Table 9. Global Venous Thromboembolism Treatment Options Market Share in Value by Type (2018-2023)
Table 10. Global Venous Thromboembolism Treatment Options Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Venous Thromboembolism Treatment Options Sales by Type (2024-2033) & (K Units)
Table 12. Global Venous Thromboembolism Treatment Options Sales Market Share in Volume by Type (2024-2033)
Table 13. Global Venous Thromboembolism Treatment Options Sales by Type (2024-2033) & (US$ Million)
Table 14. Global Venous Thromboembolism Treatment Options Sales Market Share in Value by Type (2024-2033)
Table 15. Global Venous Thromboembolism Treatment Options Price by Type (2024-2033) & (US$/Unit)
Table 16. North America Venous Thromboembolism Treatment Options Sales by Type (2018-2023) & (K Units)
Table 17. North America Venous Thromboembolism Treatment Options Sales by Type (2018-2023) & (US$ Million)
Table 18. Europe Venous Thromboembolism Treatment Options Sales (K Units) by Type (2018-2023)
Table 19. Europe Venous Thromboembolism Treatment Options Sales by Type (2018-2023) & (US$ Million)
Table 20. Asia-Pacific Venous Thromboembolism Treatment Options Sales (K Units) by Type (2018-2023)
Table 21. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Type (2018-2023) & (US$ Million)
Table 22. Latin America Venous Thromboembolism Treatment Options Sales (K Units) by Type (2018-2023)
Table 23. Latin America Venous Thromboembolism Treatment Options Sales by Type (2018-2023) & (US$ Million)
Table 24. Middle East and Africa Venous Thromboembolism Treatment Options Sales (K Units) by Type (2018-2023)
Table 25. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Type (2018-2023) & (US$ Million)
Table 26. Global Venous Thromboembolism Treatment Options Sales by Company (2018-2023) & (K Units)
Table 27. Global Venous Thromboembolism Treatment Options Sales Share by Company (2018-2023)
Table 28. Global Venous Thromboembolism Treatment Options Revenue by Company (2018-2023) & (US$ Million)
Table 29. Global Venous Thromboembolism Treatment Options Revenue Share by Company (2018-2023)
Table 30. Global Market Venous Thromboembolism Treatment Options Price by Company (2018-2023) & (US$/Unit)
Table 31. Global Venous Thromboembolism Treatment Options Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Venous Thromboembolism Treatment Options Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Venous Thromboembolism Treatment Options as of 2022)
Table 34. Date of Key Manufacturers Enter into Venous Thromboembolism Treatment Options Market
Table 35. Key Manufacturers Venous Thromboembolism Treatment Options Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Venous Thromboembolism Treatment Options Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Global Venous Thromboembolism Treatment Options Sales by Region (2018-2023) & (K Units)
Table 39. Global Venous Thromboembolism Treatment Options Sales Market Share in Volume by Region (2018-2023)
Table 40. Global Venous Thromboembolism Treatment Options Sales by Region (2018-2023) & (US$ Million)
Table 41. Global Venous Thromboembolism Treatment Options Sales Market Share in Value by Region (2018-2023)
Table 42. Global Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 43. Global Venous Thromboembolism Treatment Options Sales by Region (2024-2033) & (K Units)
Table 44. Global Venous Thromboembolism Treatment Options Sales Market Share in Volume by Region (2024-2033)
Table 45. Global Venous Thromboembolism Treatment Options Sales by Region (2024-2033) & (US$ Million)
Table 46. Global Venous Thromboembolism Treatment Options Sales Market Share in Value by Region (2024-2033)
Table 47. Global Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2033)
Table 48. Global Venous Thromboembolism Treatment Options Sales by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 49. Global Venous Thromboembolism Treatment Options Sales by Application (2018-2023) & (K Units)
Table 50. Global Venous Thromboembolism Treatment Options Sales Market Share in Volume by Application (2018-2023)
Table 51. Global Venous Thromboembolism Treatment Options Sales by Application (2018-2023) & (US$ Million)
Table 52. Global Venous Thromboembolism Treatment Options Sales Market Share in Value by Application (2018-2023)
Table 53. Global Venous Thromboembolism Treatment Options Price by Application (2018-2023) & (US$/Unit)
Table 54. Global Venous Thromboembolism Treatment Options Sales by Application (2024-2033) & (K Units)
Table 55. Global Venous Thromboembolism Treatment Options Sales Market Share in Volume by Application (2024-2033)
Table 56. Global Venous Thromboembolism Treatment Options Sales by Application (2024-2033) & (US$ Million)
Table 57. Global Venous Thromboembolism Treatment Options Sales Market Share in Value by Application (2024-2033)
Table 58. Global Venous Thromboembolism Treatment Options Price by Application (2024-2033) & (US$/Unit)
Table 59. North America Venous Thromboembolism Treatment Options Sales by Application (2018-2023) (K Units)
Table 60. North America Venous Thromboembolism Treatment Options Sales by Application (2018-2023) & (US$ Million)
Table 61. Europe Venous Thromboembolism Treatment Options Sales by Application (2018-2023) (K Units)
Table 62. Europe Venous Thromboembolism Treatment Options Sales by Application (2018-2023) & (US$ Million)
Table 63. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Application (2018-2023) (K Units)
Table 64. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Application (2018-2023) & (US$ Million)
Table 65. Latin America Venous Thromboembolism Treatment Options Sales by Application (2018-2023) (K Units)
Table 66. Latin America Venous Thromboembolism Treatment Options Sales by Application (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Application (2018-2023) (K Units)
Table 68. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Application (2018-2023) & (US$ Million)
Table 69. North America Venous Thromboembolism Treatment Options Sales by Country (2018-2023) & (K Units)
Table 70. North America Venous Thromboembolism Treatment Options Sales Market Share in Volume by Country (2018-2023)
Table 71. North America Venous Thromboembolism Treatment Options Sales by Country (2018-2023) & (US$ Million)
Table 72. North America Venous Thromboembolism Treatment Options Sales Market Share in Value by Country (2018-2023)
Table 73. North America Venous Thromboembolism Treatment Options Sales by Country (2024-2033) & (K Units)
Table 74. North America Venous Thromboembolism Treatment Options Sales Market Share in Volume by Country (2024-2033)
Table 75. North America Venous Thromboembolism Treatment Options Sales by Country (2024-2033) & (US$ Million)
Table 76. North America Venous Thromboembolism Treatment Options Sales Market Share in Value by Country (2024-2033)
Table 77. Europe Venous Thromboembolism Treatment Options Sales by Country (2018-2023) & (K Units)
Table 78. Europe Venous Thromboembolism Treatment Options Sales Market Share in Volume by Country (2018-2023)
Table 79. Europe Venous Thromboembolism Treatment Options Sales by Country (2018-2023) & (US$ Million)
Table 80. Europe Venous Thromboembolism Treatment Options Sales Market Share in Value by Country (2018-2023)
Table 81. Europe Venous Thromboembolism Treatment Options Sales by Country (2024-2033) & (K Units)
Table 82. Europe Venous Thromboembolism Treatment Options Sales Market Share in Volume by Country (2024-2033)
Table 83. Europe Venous Thromboembolism Treatment Options Sales by Country (2024-2033) & (US$ Million)
Table 84. Europe Venous Thromboembolism Treatment Options Sales Market Share in Value by Country (2024-2033)
Table 85. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Venous Thromboembolism Treatment Options Sales Market Share in Volume by Region (2018-2023)
Table 87. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Region (2018-2023) & (US$ Million)
Table 88. Asia-Pacific Venous Thromboembolism Treatment Options Sales Market Share in Value by Region (2018-2023)
Table 89. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Region (2024-2033) & (K Units)
Table 90. Asia-Pacific Venous Thromboembolism Treatment Options Sales Market Share in Volume by Region (2024-2033)
Table 91. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Region (2024-2033) & (US$ Million)
Table 92. Asia-Pacific Venous Thromboembolism Treatment Options Sales Market Share in Value by Region (2024-2033)
Table 93. Latin America Venous Thromboembolism Treatment Options Sales by Country (2018-2023) & (K Units)
Table 94. Latin America Venous Thromboembolism Treatment Options Sales Market Share in Volume by Country (2018-2023)
Table 95. Latin America Venous Thromboembolism Treatment Options Sales by Country (2018-2023) & (US$ Million)
Table 96. Latin America Venous Thromboembolism Treatment Options Sales Market Share in Value by Country (2018-2023)
Table 97. Latin America Venous Thromboembolism Treatment Options Sales by Country (2024-2033) & (K Units)
Table 98. Latin America Venous Thromboembolism Treatment Options Sales Market Share in Volume by Country (2024-2033)
Table 99. Latin America Venous Thromboembolism Treatment Options Sales by Country (2024-2033) & (US$ Million)
Table 100. Latin America Venous Thromboembolism Treatment Options Sales Market Share in Value by Country (2024-2033)
Table 101. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country (2018-2023) & (K Units)
Table 102. Middle East and Africa Venous Thromboembolism Treatment Options Sales Market Share in Volume by Country (2018-2023)
Table 103. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country (2018-2023) & (US$ Million)
Table 104. Middle East and Africa Venous Thromboembolism Treatment Options Sales Market Share in Value by Country (2018-2023)
Table 105. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country (2024-2033) & (K Units)
Table 106. Middle East and Africa Venous Thromboembolism Treatment Options Sales Market Share in Volume by Country (2024-2033)
Table 107. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country (2024-2033) & (US$ Million)
Table 108. Middle East and Africa Venous Thromboembolism Treatment Options Sales Market Share in Value by Country (2024-2033)
Table 109. AngioDynamics Company Information
Table 110. AngioDynamics Introduction and Business Overview
Table 111. AngioDynamics Venous Thromboembolism Treatment Options Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. AngioDynamics Venous Thromboembolism Treatment Options Product
Table 113. AngioDynamics Recent Development
Table 114. Cardinal Health Inc. Company Information
Table 115. Cardinal Health Inc. Introduction and Business Overview
Table 116. Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Cardinal Health Inc. Venous Thromboembolism Treatment Options Product
Table 118. Cardinal Health Inc. Recent Development
Table 119. BTG International Ltd. Company Information
Table 120. BTG International Ltd. Introduction and Business Overview
Table 121. BTG International Ltd. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. BTG International Ltd. Venous Thromboembolism Treatment Options Product
Table 123. BTG International Ltd. Recent Development
Table 124. Stryker Corporation Company Information
Table 125. Stryker Corporation Introduction and Business Overview
Table 126. Stryker Corporation Venous Thromboembolism Treatment Options Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Stryker Corporation Venous Thromboembolism Treatment Options Product
Table 128. Stryker Corporation Recent Development
Table 129. DJO Global Inc. Company Information
Table 130. DJO Global Inc. Introduction and Business Overview
Table 131. DJO Global Inc. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. DJO Global Inc. Venous Thromboembolism Treatment Options Product
Table 133. DJO Global Inc. Recent Development
Table 134. EKOS Corp Company Information
Table 135. EKOS Corp Introduction and Business Overview
Table 136. EKOS Corp Venous Thromboembolism Treatment Options Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. EKOS Corp Venous Thromboembolism Treatment Options Product
Table 138. EKOS Corp Recent Development
Table 139. Teleflex Inc., Boston Scientific Corp. Company Information
Table 140. Teleflex Inc., Boston Scientific Corp. Introduction and Business Overview
Table 141. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product
Table 143. Teleflex Inc., Boston Scientific Corp. Recent Development
Table 144. Janssen Pharmaceuticals, Inc Company Information
Table 145. Janssen Pharmaceuticals, Inc Introduction and Business Overview
Table 146. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product
Table 148. Janssen Pharmaceuticals, Inc Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Venous Thromboembolism Treatment Options Market Trends
Table 152. Venous Thromboembolism Treatment Options Market Drivers
Table 153. Venous Thromboembolism Treatment Options Market Challenges
Table 154. Venous Thromboembolism Treatment Options Market Restraints
Table 155. Venous Thromboembolism Treatment Options Distributors List
Table 156. Venous Thromboembolism Treatment Options Downstream Customers
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Venous Thromboembolism Treatment Options Product Picture
Figure 2. Global Venous Thromboembolism Treatment Options Market Size, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Venous Thromboembolism Treatment Options Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global Venous Thromboembolism Treatment Options Sales Status and Outlook (2018-2033) & (K Units)
Figure 5. Product Picture of Upper Pneumatic Compression Sleeves
Figure 6. Global Upper Pneumatic Compression Sleeves Sales YoY Growth (2018-2033) & (K Units)
Figure 7. Product Picture of Lower Pneumatic Compression Sleeves
Figure 8. Global Lower Pneumatic Compression Sleeves Sales YoY Growth (2018-2033) & (K Units)
Figure 9. Product Picture of Permanent Inferior Vena Cava Filters
Figure 10. Global Permanent Inferior Vena Cava Filters Sales YoY Growth (2018-2033) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2033) & (K Units)
Figure 13. Global Venous Thromboembolism Treatment Options Sales by Type (2018-2033) & (US$ Million)
Figure 14. Global Venous Thromboembolism Treatment Options Sales Market Share by Type in 2022 & 2033
Figure 15. North America Venous Thromboembolism Treatment Options Sales Market Share in Volume by Type in 2022
Figure 16. North America Venous Thromboembolism Treatment Options Sales Market Share in Value by Type in 2022
Figure 17. Europe Venous Thromboembolism Treatment Options Sales Market Share in Volume by Type in 2022
Figure 18. Europe Venous Thromboembolism Treatment Options Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Venous Thromboembolism Treatment Options Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Venous Thromboembolism Treatment Options Sales Market Share in Value by Type in 2022
Figure 21. Latin America Venous Thromboembolism Treatment Options Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Venous Thromboembolism Treatment Options Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Venous Thromboembolism Treatment Options Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Venous Thromboembolism Treatment Options Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Venous Thromboembolism Treatment Options Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Venous Thromboembolism Treatment Options Revenue in 2022
Figure 27. Venous Thromboembolism Treatment Options Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospitals
Figure 29. Global Hospitals Sales YoY Growth (2018-2033) & (K Units)
Figure 30. Product Picture of Catheterisation Laboratories
Figure 31. Global Catheterisation Laboratories Sales YoY Growth (2018-2033) & (K Units)
Figure 32. Product Picture of Ambulatory Surgical Centers
Figure 33. Global Ambulatory Surgical Centers Sales YoY Growth (2018-2033) & (K Units)
Figure 34. Global Venous Thromboembolism Treatment Options Sales by Application (2018-2033) & (US$ Million)
Figure 35. Global Venous Thromboembolism Treatment Options Sales Market Share by Application in 2022 & 2033
Figure 36. North America Venous Thromboembolism Treatment Options Sales Market Share in Volume by Application in 2022
Figure 37. North America Venous Thromboembolism Treatment Options Sales Market Share in Value by Application in 2022
Figure 38. Europe Venous Thromboembolism Treatment Options Sales Market Share in Volume by Application in 2022
Figure 39. Europe Venous Thromboembolism Treatment Options Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Venous Thromboembolism Treatment Options Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Venous Thromboembolism Treatment Options Sales Market Share in Value by Application in 2022
Figure 42. Latin America Venous Thromboembolism Treatment Options Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Venous Thromboembolism Treatment Options Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Venous Thromboembolism Treatment Options Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Venous Thromboembolism Treatment Options Manufacturing Cost Structure
Figure 47. Venous Thromboembolism Treatment Options Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries